165 related articles for article (PubMed ID: 17851548)
1. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.
McTiernan CF; Mathier MA; Zhu X; Xiao X; Klein E; Swan CH; Mehdi H; Gibson G; Trichel AM; Glorioso JC; Feldman AM; McCurry KR; London B
Gene Ther; 2007 Dec; 14(23):1613-22. PubMed ID: 17851548
[TBL] [Abstract][Full Text] [Related]
2. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
4. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
5. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
[TBL] [Abstract][Full Text] [Related]
7. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
[TBL] [Abstract][Full Text] [Related]
8. TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis.
Kim JM; Lim BK; Ho SH; Yun SH; Shin JO; Park EM; Kim DK; Kim S; Jeon ES
Biochem Biophys Res Commun; 2006 Jun; 344(3):765-71. PubMed ID: 16631119
[TBL] [Abstract][Full Text] [Related]
9. TNF receptor II fusion protein with tandemly repeated Fc domains.
Nagashima H; Kaneko K; Yamanoi A; Motoi S; Konakahara S; Kohroki J; Masuho Y
J Biochem; 2011 Mar; 149(3):337-46. PubMed ID: 21278157
[TBL] [Abstract][Full Text] [Related]
10. AAV vectors and cardiovascular disease: targeting TNF receptor in the heart: clue to way forward with AAV?
Hajjar RJ; Zsebo K
Gene Ther; 2007 Dec; 14(23):1611-2. PubMed ID: 17943145
[No Abstract] [Full Text] [Related]
11. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats.
Müller OJ; Schinkel S; Kleinschmidt JA; Katus HA; Bekeredjian R
Gene Ther; 2008 Dec; 15(23):1558-65. PubMed ID: 18615116
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE
J Rheumatol; 2010 Apr; 37(4):692-703. PubMed ID: 20032102
[TBL] [Abstract][Full Text] [Related]
13. Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus.
Kaspar BK; Roth DM; Lai NC; Drumm JD; Erickson DA; McKirnan MD; Hammond HK
J Gene Med; 2005 Mar; 7(3):316-24. PubMed ID: 15515115
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis.
Adachi O; Nakano A; Sato O; Kawamoto S; Tahara H; Toyoda N; Yamato E; Matsumori A; Tabayashi K; Miyazaki J
Gene Ther; 2002 May; 9(9):577-83. PubMed ID: 11973633
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IL-10 and MCP-1-7ND gene transfer with AAV9 vectors for protection from murine autoimmune myocarditis.
Kaya Z; Leib C; Werfel S; Göser S; Öttl R; Leuchs B; Pfitzer G; Katus HA; Müller OJ
Cardiovasc Res; 2011 Jul; 91(1):116-23. PubMed ID: 21354997
[TBL] [Abstract][Full Text] [Related]
16. Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II.
Franco LM; Sun B; Yang X; Bird A; Zhang H; Schneider A; Brown T; Young SP; Clay TM; Amalfitano A; Chen YT; Koeberl DD
Mol Ther; 2005 Nov; 12(5):876-84. PubMed ID: 16005263
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
Pechan P; Rubin H; Lukason M; Ardinger J; DuFresne E; Hauswirth WW; Wadsworth SC; Scaria A
Gene Ther; 2009 Jan; 16(1):10-6. PubMed ID: 18633446
[TBL] [Abstract][Full Text] [Related]
18. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
[TBL] [Abstract][Full Text] [Related]
19. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
Koeberl DD; Sun BD; Damodaran TV; Brown T; Millington DS; Benjamin DK; Bird A; Schneider A; Hillman S; Jackson M; Beaty RM; Chen YT
Gene Ther; 2006 Sep; 13(17):1281-9. PubMed ID: 16672983
[TBL] [Abstract][Full Text] [Related]
20. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
Le HT; Yu QC; Wilson JM; Croyle MA
J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]